Our previous studies indicated that GPR56 regulates fibronectin content in xenograft tumors, and due to the role of ECM in cancer growth and metastasis we predicted that GPR56 might inhibit metastatic growth through its effects on ECM (18). Here, FN1 is linked to cancer.